 |
 |

Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: We would like to raise possible reasons for the treatment failure of granulocyte colony-stimulating factor (G-CSF) in the Regenerate Vital Myocardium by Vigorous Activation of Bone Marrow Stem Cells (REVIVAL-2) trial by Dr Zohlnhöfer and colleagues1 based on what we believe to be the mechanism of action of G-CSF in both the myocardium and the brain.
Protective effects of G-CSF in experimental acute myocardial infarction (AMI) or stroke have been shown,2-4 but the probable mechanism of action has remained uncertain. Most studies have assumed activation and mobilization of bone marrowderived stem cells by G-CSF that integrate into the infarcted organ and contribute to recovery by transdifferentiation or other unknown mechanisms. Based on this assumption, REVIVAL-2 was designed with a delayed treatment start (5 days after AMI), and with a G-CSF dose sufficient to stimulate bone marrow mobilization (10 µg/kg per day for 5 days).1 However, recent evidence . . . [Full Text of this Article]
Wolf-Rüdiger Schäbitz, MD
schabitz@uni-muenster.de Department of Neurology
Sigrid Nikol, MD
Department of Cardiology University of Münster Münster, Germany
Armin Schneider
Axaron Bioscience AG Heidelberg, Germany
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction
Jaewon Oh, Dae Hyun Kim, and Hyunseok Kang
JAMA. 2006;296(16):1968.
EXTRACT
| FULL TEXT
Granulocyte Colony-Stimulating Factor and Acute Myocardial InfarctionReply
Dietlind Zohlnhöfer, Ilka Ott, Adnan Kastrati, and Albert Schömig
JAMA. 2006;296(16):1968-1969.
EXTRACT
| FULL TEXT
Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial Infarction: A Randomized Controlled Trial
Dietlind Zohlnhöfer, Ilka Ott, Julinda Mehilli, Kathrin Schömig, Fabian Michalk, Tareq Ibrahim, Günther Meisetschläger, Jasper von Wedel, Hildegard Bollwein, Melchior Seyfarth, Josef Dirschinger, Claus Schmitt, Markus Schwaiger, Adnan Kastrati, Albert Schömig, and for the REVIVAL-2 Investigators
JAMA. 2006;295(9):1003-1010.
ABSTRACT
| FULL TEXT
|